Trials / Completed
CompletedNCT00004306
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Office of Rare Diseases (ORD) · NIH
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
Detailed description
PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation. Studies include: neurologic evaluation, including magnetic resonance imaging and nerve conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation. A neuropathologic evaluation is conducted postmortem, when possible.
Conditions
Timeline
- Start date
- 1999-11-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 1999-10-19
- Last updated
- 2012-03-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00004306. Inclusion in this directory is not an endorsement.